Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees

It was a big year for ever-bigger CVS Health, which notched a 5% increase in annual revenue, to $195 billion, as it closed its $70 billion acquisition of insurer Aetna. The Rhode Island retailer saw particular strength in its pharmacy business—thanks to more network claims and increased prescription volume—even as downward price pressure continued. But all eyes remain on Aetna, and so far, it’s tough sledding. An underwhelming February forecast, and acknowledgment that CVS would have to invest in Aetna as much as it expected to save in the deal, disappointed investors and led to its share price dropping 20% to below $55. Can CVS cure what ails it? That depends in part on what happens in Washington. In May, CEO Larry Merlo joined industry peers in criticizing proposed “Medicare for All” legislation that would eliminate private insurers and disrupt the American health care system.

Company Info

Acquired Aetna (2017 rank: 49), Nov. 28, 2018.
Larry J. Merlo
CEO Title
President, Chief Executive Officer & Director
Health Care
Health Care: Pharmacy and Other Services
HQ Location
Woonsocket, R.I.
Years on Fortune 500 List26

CVS Health Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$194,579.05.3%
Profits ($M)$-594.0-109.0%
Assets ($M)$196,456.0-
Total Stockholder Equity ($M)$58,225.0-

Profit Ratios

Profit as % of Revenues-0.3%
Profits as % of Assets-0.3%
Profits as % of Stockholder Equity-1.0%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)-0.57
EPS % Change (from 2017)-108.9%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2018)-7.0%
Total Return to Investors (5 year, annualized)0.3%
Total Return to Investors (10 year, annualized)10.4%